Your browser doesn't support javascript.
loading
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms.
Spinner, Michael A; Aleshin, Alexey; Santaguida, Marianne T; Schaffert, Steven A; Zehnder, James L; Patterson, A Scott; Gekas, Christos; Heiser, Diane; Greenberg, Peter L.
Afiliação
  • Spinner MA; Division of Hematology, Department of Medicine, Stanford University Medical Center, Stanford, CA; and.
  • Aleshin A; Division of Hematology, Department of Medicine, Stanford University Medical Center, Stanford, CA; and.
  • Santaguida MT; Notable Labs, Foster City, CA.
  • Schaffert SA; Notable Labs, Foster City, CA.
  • Zehnder JL; Division of Hematology, Department of Medicine, Stanford University Medical Center, Stanford, CA; and.
  • Patterson AS; Notable Labs, Foster City, CA.
  • Gekas C; Notable Labs, Foster City, CA.
  • Heiser D; Notable Labs, Foster City, CA.
  • Greenberg PL; Division of Hematology, Department of Medicine, Stanford University Medical Center, Stanford, CA; and.
Blood Adv ; 4(12): 2768-2778, 2020 06 23.
Article em En | MEDLINE | ID: mdl-32569379

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Preparações Farmacêuticas / Leucemia Mieloide Aguda Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Preparações Farmacêuticas / Leucemia Mieloide Aguda Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article